Neurotrophic tyrosine kinase receptor type 2 (NTRK2) gene associated with treatment response to mood stabilizers in patients with bipolar i disorder

Journal of Molecular Neuroscience

Volumn 50, Issue 2, 2013, Pages 305-310

  Wang, Zuowei ^a,b   Fan, Jinbo ^c   Gao, Keming ^c   Li, Zezhi ^a   Yi, Zhenghui ^a   Wang, Lingxiao ^a   Huang, Jia ^a   Yuan, Chengmei ^a   Hong, Wu ^a   Yu, Shunying ^a   Fang, Yiru ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Mental Health Centre of Hongkou District   (China)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Association; Bipolar disorder; Brain derived neurotrophic factor (BDNF); Neurotrophic tyrosine kinase receptor type 2 (NTRK2); Polymorphism

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; LITHIUM; MOOD STABILIZER; VALPROIC ACID;

ADULT; ALLELE; ARTICLE; BIPOLAR I DISORDER; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DSM-IV; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, TRKB; TREATMENT OUTCOME;

EID: 84878244322     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-9956-0     Document Type: Article

References (26)

1. Bremer T, Diamond C, McKinney R et al (2007) The pharmacogenetics of lithium response depends upon clinical co-morbidity. Mol Diagn Ther 11:161-170
2. Dmitrzak-Weglarz M, Rybakowski JK, Suwalska A et al (2008) Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients. Pharmacogenomics 9:1595-1603
3. Dunham JS, Deakin JF, Miyajima F, Payton A, Toro CT (2009) Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. J Psychiatr Res 43:1175-1184
4. Einat H, Manji HK (2006) Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biol Psychiatry 59:1160-1171
5. Fan J, Sklar P (2008) Genetics of bipolar disorder: focus on BDNF Val66Met polymorphism. Novartis Found Symp 289:60-72
6. Farmer A, Elkin A, McGuffin P (2007) The genetics of bipolar affective disorder. Curr Opin Psychiatry 20:8-12
7. First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured clinical interview for DSM-IV axis I disorders, patient version. American Psychiatric Press, Washington DC
8. Gao K, Calabrese JR (2005) Newer treatment studies for bipolar depression. Bipolar Disorders 7(suppl 5):13-23
9. Garnham J, Munro A, Slaney C et al (2007) Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study. J Affect Disord 104:185-190
10. Grof P, Duffy A, Cavazzoni P et al (2002) Is response to prophylactic lithium a familial trait? J Clin Psychiatry 63:942-947
11. Hashimoto K, Shimizu E, Iyo M (2004) Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 45:104-114
12. Hayden EP, Nurnberger JI Jr (2006) Molecular genetics of bipolar disorder. Genes Brain Behav 5:85-95
13. Hosang GM, Uher R, Keers R et al (2010) Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. J Affect Disord 125:345-349
14. Kremeyer B, Herzberg I, Garcia J et al (2006) Transmission distortion of BDNF variants to bipolar disorder type I patients from a South American population isolate. Am J Med Genet B Neuropsychiatr Genet 141B:435-439
15. Luberg K, Wong J, Weickert CS, Timmusk T (2010) Human TrkB gene: novel alternative transcripts, protein isoforms and expression pattern in the prefrontal cerebral cortex during postnatal development. J Neurochem 113:952-964
16. Murphy ML, Carballedo A, Fagan AJ et al (2012) Neurotrophic tyrosine kinase polymorphism impacts white matter connections in patients with major depressive disorder. Biol Psychiatry 72:663-670
17. Petryshen TL, Sabeti PC, Aldinger KA et al (2010) Population genetic study of the brain-derived neurotrophic factor (BDNF) gene. Mol Psychiatry 15:810-815
18. Rybakowski JK, Czerski P, Dmitrzak-Weglarz M et al (2012) Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy. J Psychopharmacol 26:368-373
19. Shaltiel G, Chen G, Manji HK (2007) Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr Opin Pharmacol 7:22-26
20. Smith EN, Bloss CS, Badner JA et al (2009) Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 14:755-763
21. Smoller JW, Finn CT (2003) Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 123C:48-58
22. Thompson Ray M, Weickert CS, Wyatt E, Webster MJ (2011) Decreased BDNF, trkB-TK + and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci 36:195-203
23. Vinberg M, Trajkovska V, Bennike B, Knorr U, Knudsen GM, Kessing LV (2009) The BDNF Val66Met polymorphism: relation to familiar risk of affective disorder, BDNF levels and salivary cortisol. Psychoneuroendocrinology 34:1380-1389
24. Xu J, Liu Y, Wang P et al (2010) Positive association between the brain-derived neurotrophic factor (BDNF) gene and bipolar disorder in the Han Chinese population. Am J Med Genet B Neuropsychiatr Genet 153B:275-279
25. Zandi PP, Judy JT (2010) The promise and reality of pharmacogenetics in psychiatry. Psychiatr Clin North Am 33:181-224
26. Zarate CA Jr, Singh J, Manji HK (2006) Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 59:1006-1020